Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sauflon Pharmaceuticals, LTD
WARNING LETTER
•Sauflon Pharmaceuticals, LTD

Sauflon Pharmaceuticals, LTD – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Sauflon Pharmaceuticals, LTD, regarding their "i-Clean' antibacterial contact lens soaking case." The FDA determined that the product is a medical device marketed in the U.S. without required marketing clearance or approval, violating the Federal Food, Drug, and Cosmetic Act.

The "i-Clean" case's labeling, including the screw top lens cap and display placard, states "antibacterial," indicating an antibacterial use. While Sauflon Pharmaceuticals obtained 510(k) clearance for a different device, the Flat Colored Contact Lens Case (K052809), in 2005 for storage during chemical disinfection, they have not obtained 510(k) clearance for the "i-Clean' antibacterial contact lens soaking case."

This constitutes several violations: the device is adulterated under section 501(f)(1)(B) of the Act because there is no approved premarket approval (PMA) or investigational device exemption (IDE). It is also misbranded under section 502(o) of the Act for failure to notify the FDA of intent to introduce the device into commercial distribution as required by section 510(k).

Sauflon Pharmaceuticals is required to immediately cease dissemination of promotional materials for the "i-Clean" case and take prompt action to correct the violations. Due to the serious nature of the violations, "i-Clean"

Company
Sauflon Pharmaceuticals, LTD
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Timothy A. Ulatowski (Director)
  • Ronald L. Swann (Associate Director )
View Company Profile

ID · 7e4c40a6-a66f-45ab-9a14-f8a3514ba2b2

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)21 CFR 807.81(b)21 U.S.C. 381(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sauflon Pharmaceuticals, LTD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.